[go: up one dir, main page]

NO20085137L - Nasal and buccal compositions for controlling snoring - Google Patents

Nasal and buccal compositions for controlling snoring

Info

Publication number
NO20085137L
NO20085137L NO20085137A NO20085137A NO20085137L NO 20085137 L NO20085137 L NO 20085137L NO 20085137 A NO20085137 A NO 20085137A NO 20085137 A NO20085137 A NO 20085137A NO 20085137 L NO20085137 L NO 20085137L
Authority
NO
Norway
Prior art keywords
nasal
snoring
buccal compositions
controlling snoring
controlling
Prior art date
Application number
NO20085137A
Other languages
Norwegian (no)
Inventor
Serge Sonie
Jean-Christophe Anton
Denis Marin
Original Assignee
Omega Pharma Capital Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0651998A external-priority patent/FR2901705A1/en
Application filed by Omega Pharma Capital Nv filed Critical Omega Pharma Capital Nv
Publication of NO20085137L publication Critical patent/NO20085137L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Oppfinnelsen er relatert til anvendelsen av en nasal sammensetning og en bukkal sammensetning for fremstilling av en kombinert sammensetning som skal bli benyttet samtidig, sekvensielt eller separat for behandlingen eller forebyggingen av snorking, spesielt for en person som snorker kraftig.The invention relates to the use of a nasal composition and a buccal composition for the preparation of a combined composition to be used simultaneously, sequentially or separately for the treatment or prevention of snoring, especially for a person who is snoring heavily.

NO20085137A 2006-06-01 2008-12-10 Nasal and buccal compositions for controlling snoring NO20085137L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0651998A FR2901705A1 (en) 2006-06-01 2006-06-01 COMPOSITION FOR FIGHT AGAINST SNORING IN THE FORM OF A NASAL SPRAY
FR0701176A FR2901706A1 (en) 2006-06-01 2007-02-19 NASAL AND ORAL COMPOSITIONS TO FIGHT THE SNOW
PCT/FR2007/051341 WO2007138224A1 (en) 2006-06-01 2007-05-29 Nasal and buccal compositions for controlling snoring

Publications (1)

Publication Number Publication Date
NO20085137L true NO20085137L (en) 2009-02-27

Family

ID=38647216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085137A NO20085137L (en) 2006-06-01 2008-12-10 Nasal and buccal compositions for controlling snoring

Country Status (13)

Country Link
EP (1) EP2026835B1 (en)
JP (1) JP2009538888A (en)
AU (1) AU2007266902A1 (en)
BR (1) BRPI0711253A2 (en)
CA (1) CA2653916A1 (en)
EA (1) EA200802262A1 (en)
ES (1) ES2434113T3 (en)
FR (1) FR2901706A1 (en)
MA (1) MA30489B1 (en)
NO (1) NO20085137L (en)
RU (1) RU2008146888A (en)
TN (1) TNSN08497A1 (en)
WO (1) WO2007138224A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008189568A (en) * 2007-02-02 2008-08-21 Sceti Kk Composition for liquid preparation or film-like preparation for oral cavity for prophylaxis or therapy of snoring disease and product for oral cavity comprising the same
FR2940761B1 (en) * 2009-01-07 2012-12-28 Polymerexpert Sa ANTI-ROUNDER COMPOSITION CONTAINING A THERMOGELIFYING POLYMER
CN105982669A (en) * 2015-03-02 2016-10-05 罗远明 Airway resistance judgment based on diaphragmatic electromyogram

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2485530A1 (en) * 2002-02-15 2003-08-28 Cns, Inc. Throat spray
EP1517673A1 (en) * 2002-06-20 2005-03-30 Novartis Consumer Health S.A. Nasal composition comprising a mucopolysaccharide and propylene glycol
PL375621A1 (en) * 2002-10-24 2005-12-12 Immupharm A/S Pharmaceutical compositions containing flavonoids and menthol
FR2876585B1 (en) * 2004-10-20 2008-09-12 Persee Medica COMPOSITION FOR FIGHT AGAINST SNOW

Also Published As

Publication number Publication date
BRPI0711253A2 (en) 2011-08-30
WO2007138224A1 (en) 2007-12-06
JP2009538888A (en) 2009-11-12
EA200802262A1 (en) 2009-08-28
AU2007266902A1 (en) 2007-12-06
RU2008146888A (en) 2010-07-20
ES2434113T3 (en) 2013-12-13
FR2901706A1 (en) 2007-12-07
MA30489B1 (en) 2009-06-01
EP2026835A1 (en) 2009-02-25
TNSN08497A1 (en) 2010-04-14
CA2653916A1 (en) 2007-12-06
EP2026835B1 (en) 2013-08-21

Similar Documents

Publication Publication Date Title
WO2007143674A3 (en) Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
BRPI0516483A (en) preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
IN2012DN00624A (en)
WO2008011363A3 (en) Quercetin-containing compositions
LT2695609T (en) ORAL COMPOSITION AND USES OF CITIDINE ANALOGUE FOR ORAL USE
DK1773361T3 (en) Composition based on probiotic bacteria and its use for the prevention and / or treatment of respiratory diseases and / or infections and for the improvement of intestinal functionality
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ZA200808022B (en) Inhibitors of human immunodeficiency virus replication
MY164646A (en) Nicotine lozenge compositions
PL1986669T3 (en) The use of Bifidobacterium longum for the prevention and treatment of inflammation
WO2008058274A3 (en) Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization
NZ589293A (en) Antiallergic marine biopolymers comprising iota-carrageenan
WO2007142811A3 (en) Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
NO20092073L (en) C3A receptor modulators, and methods for their use
WO2009068708A8 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
ZA201007091B (en) Vaccine compositions for the treatment of dengue fever and uses thereof
WO2009095423A3 (en) Oral care composition for combating dentine hypersensitivity
EP2170932A4 (en) Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
NO20083901L (en) Fixed-dose association of phytate and zinc
WO2008028003A3 (en) Denture care composition
NO20085137L (en) Nasal and buccal compositions for controlling snoring
WO2009123486A8 (en) Use of compounds in the treatment of tau-induced cytotoxicities
WO2009006246A8 (en) Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application